Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Angela Whiley is active.

Publication


Featured researches published by Angela Whiley.


Journal of Clinical Microbiology | 2008

Colonization and persistence of antibiotic-resistant Enterobacteriaceae strains in infants nursed in two neonatal intensive care units in East London, United Kingdom.

Michael Millar; Alex Philpott; Mark Wilks; Angela Whiley; Simon Warwick; Enid Hennessy; Pietro G. Coen; Stephen T. Kempley; Fiona Stacey; Kate Costeloe

ABSTRACT Stool samples were collected from infants nursed in two neonatal intensive care units (NICUs) in East London, United Kingdom. The aim of the study was to determine the incidence of and risk factors for the carriage of multiresistant Enterobacteriaceae strains (MRE; resistant to three or more classes of antibiotic) and the extent of the persistence of resistant strains following discharge. Sixty-two (50%) of 124 infants had acquired MRE by 2 weeks of postnatal age, and 69 (56%) infants had acquired MRE by discharge. The proportions of infants at 2 weeks carrying strains that were resistant to antibiotics were the following: tetracycline, 79%; amoxicillin, 78%; cephalosporins, 31%; trimethoprim, 20%; piperacillin-tazobactam, 11%; chloramphenicol, 9%; and aminoglycoside, 4%. A gestational age of less than 26 weeks was a risk factor for colonization with MRE at discharge, but not at 2 weeks. Analysis within a NICU showed that exposure of an infant to a specific antibiotic in the NICU was not a risk factor for the carriage of a strain resistant to that antibiotic. Estimates of persistence from discharge to 6 months were the following: for tetracycline, 57% (95% confidence intervals [CI], 0.35 to 0.87); chloramphenicol, 49% (95% CI, 0.20 to 0.83); trimethoprim, 45% (95% CI, 0.22 to 0.74); piperacillin-tazobactam, 42% (95% CI, 0.20 to 0.71); and augmentin, 34% (95% CI, 0.11 to 0.66). Strains resistant to cephalosporins or aminoglycosides showed lower levels of persistence. Nine of 34 infants (26.5%) with Escherichia coli and 4 (7.1%) of 56 infants with Klebsiella spp. at discharge carried strains indistinguishable by randomly amplified polymorphic DNA and antibiotic susceptibility patterns at 6 months. MRE were found at high frequency in the infants during their stay in the NICU and persisted in a proportion of infants.


Journal of Antimicrobial Chemotherapy | 2016

ESBL-producing Enterobacteriaceae in 24 neonatal units and associated networks in the south of England: no clustering of ESBL-producing Escherichia coli in units or networks

Michael Millar; Jo Seale; Jane F. Turton; Mark Wilks; Kate Costeloe; Neil Woodford; Ed Juszczak; Angela Whiley; Nicola Panton; David W. Wareham

OBJECTIVES The objectives of this study were to characterize ESBL-producing Enterobacteriaceae present in 24 neonatal units (NNUs) in eight networks participating in a multicentre probiotic study and to test the hypothesis that specific strains would cluster within individual units and networks. METHODS We performed analysis of stool samples for the presence of ESBL-producing Enterobacteriaceae at 2 weeks post-natal age and 36 weeks post-menstrual age. ESBL-producing Enterobacteriaceae were characterized and typed using molecular methods. RESULTS ESBL-producing Enterobacteriaceae (n = 71) were isolated from 67/1229 (5.5%) infants from whom we received a sample at either sampling time or both sampling times, and from infants in 18 (75%) of the 24 recruiting NNUs. Thirty-three Escherichia coli, 23 Klebsiella spp. and 6 Enterobacter spp. strains were characterized. ESBL-producing E. coli were all distinguishable within individual NNUs by antibiotic resistance genotype, serogroup (O25b), phenotype, phylotype or ST. Ten of the 33 were ST131 and 9 of the 10 ST131 isolates were ciprofloxacin resistant. Seven of the 10 ST131 isolates carried genes encoding CTX-M group 1 enzymes. ST131 isolates were isolated from centres within five of the eight NNU networks. There were clusters of indistinguishable ESBL-producing Klebsiella and Enterobacter isolates associated with specific NNUs. CONCLUSIONS Strains of E. coli ST131 were distributed across neonatal networks in the south of England. There was no evidence of clustering of clonally related ESBL-producing E. coli strains, by contrast with Klebsiella spp. and Enterobacter spp., which did cluster within units. The possibility that ESBL-producing E. coli strains are spread by vertical transmission requires further investigation.


Journal of Infection | 2017

Toxigenic Clostridium difficile colonization among hospitalised adults; risk factors and impact on survival

Laura Behar; David Chadwick; Angela Dunne; Christopher I. Jones; Claire Proctor; Chakravarthi Rajkumar; Paula Sharratt; Philip Stanley; Angela Whiley; Mark Wilks; Martin Llewelyn

Summary Objectives To establish risk factors for Clostridium difficile colonization among hospitalized patients in England. Methods Patients admitted to elderly medicine wards at three acute hospitals in England were recruited to a prospective observational study. Participants were asked to provide a stool sample as soon as possible after enrolment and then weekly during their hospital stay. Samples were cultured for C. difficile before ribotyping and toxin detection by PCR. A multivariable logistic regression model of risk factors for C. difficile colonization was fitted from univariable risk factors significant at the p < 0.05 level. Results 410/727 participants submitted ≥1 stool sample and 40 (9.8%) carried toxigenic C. difficile in the first sample taken. Ribotype 106 was identified three times and seven other ribotypes twice. No ribotype 027 strains were identified. Independent predictors of colonization were previous C. difficile infection (OR 4.53 (95% C.I. 1.33–15.48) and malnutrition (MUST score ≥2) (OR 3.29 (95% C.I. 1.47–7.35)). Although C. difficile colonised patients experienced higher 90-day mortality, colonization was not an independent risk for death. Conclusions In a non-epidemic setting patients who have previously had CDI and have a MUST score of ≥2 are at increased risk of C. difficile colonization and could be targeted for active surveillance to prevent C. difficile transmission.


Journal of Clinical Microbiology | 2004

Identification and H2O2 Production of Vaginal Lactobacilli from Pregnant Women at High Risk of Preterm Birth and Relation with Outcome

Mark Wilks; Rebecca Wiggins; Angela Whiley; Enid Hennessy; Simon Warwick; Helen Porter; Anthony P. Corfield; Michael Millar


Journal of Hospital Infection | 2005

Competition between methicillin-sensitive and -resistant Staphylococcus aureus in the anterior nares

M. Dall'Antonia; Pietro G. Coen; Mark Wilks; Angela Whiley; Michael Millar


Health Technology Assessment | 2016

A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial

Kate Costeloe; Ursula Bowler; Peter Brocklehurst; Pollyanna Hardy; Paul Heal; Edmund Juszczak; Andrew J. King; Nicola Panton; Fiona Stacey; Angela Whiley; Mark Wilks; Michael Millar


Scientific Reports | 2017

Identification of low oxygen-tolerating bacteria in prostate secretions of cancer patients and discussion of possible aetiological significance

Roshni Bhudia; Amar Ahmad; Onyinye Akpenyi; Angela Whiley; Mark Wilks; Tim Oliver


Archive | 2016

Guidance sheet 3: preparation and administration of the trial intervention

Kate Costeloe; Ursula Bowler; Peter Brocklehurst; Pollyanna Hardy; Paul Heal; Edmund Juszczak; Andrew J. King; Nicola Panton; Fiona Stacey; Angela Whiley; Mark Wilks; Michael Millar


Archive | 2016

Probiotics in Preterm infantS trial sites

Kate Costeloe; Ursula Bowler; Peter Brocklehurst; Pollyanna Hardy; Paul Heal; Edmund Juszczak; Andrew J. King; Nicola Panton; Fiona Stacey; Angela Whiley; Mark Wilks; Michael Millar


Archive | 2016

Form 1: trial entry

Kate Costeloe; Ursula Bowler; Peter Brocklehurst; Pollyanna Hardy; Paul Heal; Edmund Juszczak; Andrew J. King; Nicola Panton; Fiona Stacey; Angela Whiley; Mark Wilks; Michael Millar

Collaboration


Dive into the Angela Whiley's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kate Costeloe

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar

Fiona Stacey

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar

Nicola Panton

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul Heal

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge